Daniel J. Griffin

Amgen (United States)

Papers

1

Total Citations

74

H-Index

1

About

Daniel J. Griffin is a leading researcher at the intersection of automation, computer vision, and pharmaceutical chemistry, with a primary focus on transforming labor-intensive laboratory workflows. His most impactful work centers on the development of automated solubility screening platforms, a critical yet traditionally manual process in drug discovery. Griffin’s landmark 2021 paper, “Automated solubility screening platform using computer vision” (74 citations), introduced a novel system that replaces conventional, time-consuming analytic techniques like high-performance liquid chromatography with rapid, image-based analysis. This contribution significantly accelerates early-stage drug development by enabling high-throughput, reliable solubility assessments with minimal human intervention. By integrating robotics with advanced computer vision algorithms, Griffin has addressed a key bottleneck in pharmaceutical research, offering a scalable solution that reduces both cost and error. His work has been widely adopted and cited by labs seeking to modernize their screening pipelines, establishing him as a pivotal figure in the push toward fully automated, AI-driven laboratory environments.

Research Focus

Key Achievements

1
H-Index
1
Papers
74
Total Citations
74
Avg Citations/Paper
🏆 Most Cited Paper
Automated solubility screening platform using computer vision
74 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Amgen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago